 |
인쇄하기
취소
|
LG Chem starts to aim for rheumatoid arthritis market
LG Chem will start to aim for the Korean rheumatoid arthritis market.
LG Chem announced on the 28th that the company start to sell a rheumatoid arthritis therapy ‘Eucept(generic name: etanercept)’ in Korea.
Eucept, the LG Chem’s first antibody, was approved for the treatment of ▲rheumatoid arthritis, ▲psoriatic arthritis, ▲axial spondyloarthritis and ▲psoriasis.
LG Chem is planning to rapidl...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.